Literature DB >> 33732235

Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery.

Pierre-Olivier Ludes1,2, Charles de Roquetaillade3,4, Benjamin Glenn Chousterman3,4, Julien Pottecher1,2, Alexandre Mebazaa3,4.   

Abstract

Damage-associated molecular patterns (DAMPs) are a group of immunostimulatory molecules, which take part in inflammatory response after tissue injury. Kidney-specific DAMPs include Tamm-Horsfall glycoprotein, crystals, and uromodulin, released by tubular damage for example. Non-kidney-specific DAMPs include intracellular particles such as nucleus [histones, high-mobility group box 1 protein (HMGB1)] and cytosol parts. DAMPs trigger innate immunity by activating the NRLP3 inflammasome, G-protein coupled class receptors or the Toll-like receptor. Tubular necrosis leads to acute kidney injury (AKI) in either septic, ischemic or toxic conditions. Tubular necrosis releases DAMPs such as histones and HMGB1 and increases vascular permeability, which perpetuates shock and hypoperfusion via Toll Like Receptors. In acute tubular necrosis, intracellular abundance of NADPH may explain a chain reaction where necrosis spreads from cell to cell. The nature AKI in intensive care units does not have preclinical models that meet a variation of blood perfusion or a variation of glomerular filtration within hours before catecholamine infusion. However, the dampening of several DAMPs in AKI could provide organ protection. Research should be focused on the numerous pathophysiological pathways to identify the relative contribution to renal dysfunction. The therapeutic perspectives could be strategies to suppress side effect of DAMPs and to promote renal function regeneration.
Copyright © 2021 Ludes, de Roquetaillade, Chousterman, Pottecher and Mebazaa.

Entities:  

Keywords:  DAMPs; acute kidney injury; clinical features; kidney recovery; precision medicine; sepsis; therapeutic targets

Mesh:

Substances:

Year:  2021        PMID: 33732235      PMCID: PMC7957065          DOI: 10.3389/fimmu.2021.606622

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  140 in total

Review 1.  Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.

Authors:  Ann Marshak-Rothstein; Ian R Rifkin
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

2.  Toll-like receptor 4-induced IL-22 accelerates kidney regeneration.

Authors:  Onkar P Kulkarni; Ingo Hartter; Shrikant R Mulay; Jan Hagemann; Murthy N Darisipudi; Santhosh Kumar Vr; Simone Romoli; Dana Thomasova; Mi Ryu; Sebastian Kobold; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

3.  Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates.

Authors:  Tolga Sursal; Deborah J Stearns-Kurosawa; Kiyoshi Itagaki; Sun-Young Oh; Shiqin Sun; Shinichiro Kurosawa; Carl J Hauser
Journal:  Shock       Date:  2013-01       Impact factor: 3.454

4.  TLR2 plays a role in the activation of human resident renal stem/progenitor cells.

Authors:  Fabio Sallustio; Luc De Benedictis; Giuseppe Castellano; Gianluigi Zaza; Antonia Loverre; Vincenzo Costantino; Giuseppe Grandaliano; Francesco P Schena
Journal:  FASEB J       Date:  2009-10-20       Impact factor: 5.191

Review 5.  The role of innate immune responses in autoimmune disease development.

Authors:  Hanspeter Waldner
Journal:  Autoimmun Rev       Date:  2009-01-20       Impact factor: 9.754

Review 6.  The clinical relevance of necroinflammation-highlighting the importance of acute kidney injury and the adrenal glands.

Authors:  Wulf Tonnus; Florian Gembardt; Markus Latk; Simon Parmentier; Christian Hugo; Stefan R Bornstein; Andreas Linkermann
Journal:  Cell Death Differ       Date:  2018-09-17       Impact factor: 15.828

Review 7.  Acute Kidney Injury in Western Countries.

Authors:  Josée Bouchard; Ravindra L Mehta
Journal:  Kidney Dis (Basel)       Date:  2016-03-30

Review 8.  DAMPs from Cell Death to New Life.

Authors:  Emilie Vénéreau; Chiara Ceriotti; Marco Emilio Bianchi
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561

Review 9.  Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis.

Authors:  Noémie Simon; Alexandre Hertig
Journal:  Front Med (Lausanne)       Date:  2015-08-05

Review 10.  Targeting Inflammation Driven by HMGB1.

Authors:  Huan Yang; Haichao Wang; Ulf Andersson
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

View more
  6 in total

1.  The Pathophysiology of Sepsis-Associated AKI.

Authors:  Shuhei Kuwabara; Eibhlin Goggins; Mark D Okusa
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-28       Impact factor: 10.614

Review 2.  Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury.

Authors:  Takahiro Uchida; Shuhji Seki; Takashi Oda
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

Review 3.  Involvement of Inflammasome Components in Kidney Disease.

Authors:  Ana Karina Aranda-Rivera; Anjali Srivastava; Alfredo Cruz-Gregorio; José Pedraza-Chaverri; Shrikant R Mulay; Alexandra Scholze
Journal:  Antioxidants (Basel)       Date:  2022-01-27

Review 4.  Disruption of Kidney-Immune System Crosstalk in Sepsis with Acute Kidney Injury: Lessons Learned from Animal Models and Their Application to Human Health.

Authors:  Kaice LaFavers
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 6.208

Review 5.  The complement system in pediatric acute kidney injury.

Authors:  Erin K Stenson; Jessica Kendrick; Bradley Dixon; Joshua M Thurman
Journal:  Pediatr Nephrol       Date:  2022-10-06       Impact factor: 3.651

Review 6.  Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases.

Authors:  Paulina Mertowska; Sebastian Mertowski; Iwona Smarz-Widelska; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.